Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Antibiotics
24 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Molecular Machines
The Potential of Molecular Machines: Enhanced Drug Delivery and Beyond
PAO-01-24-NI-02
Antibiotic Resistance
Antibiotic Resistance: Advances in Understanding and Drug Development
PAO-10-022-NI-07
Antimicrobial
Preserving the Value of Critical Anti-Infectives
PAO-04-22-R221-20
Antibiotics
Sandoz Announces Plans for Joint Investment to Help Strengthen Future of Antibiotics Manufacturing in Europe
PR-M07-20-NI-38
Nice Insight Overview
Drug Approval Trends: Significant Acceleration in Recent Years
PAP-Q2-20-NI-001
Molecules
Molecules that Changed Medicine
PAP-Q2-20-NI-002
Novel Antibiotics
Applying a Synthetic Approach to the Development of a New Generation of Antibiotics
PAP-Q2-20-CL-019
FDA Approval
FDA Approves New Antibiotic to Treat Community-Acquired Bacterial Pneumonia
PR-M08-19-NI-061
Antibiotics
UK Hopes Subscription Payment Model Will Drive Innovation in Antibiotics
PAO-M08-19-NI-006
Priority Review
Melinta’s Antibiotic Baxdela Gets Priority Review from FDA for CAPB
PAO-M07-19-NI-005
Antibiotic Resistant
FIU Scientists Discover New Arsenic-Based Broad-Spectrum Antibiotic
PR-M04-19-NI-058
Antibiotics
Infectious Diseases Experts Convene to Explore Lifesaving Antibiotic Research Methods
PR-M11-18-NI-052
Investment
Qpex Biopharma Announces Closing of $33 Million Series A Financing and Launch of Company to Address Worldwide Problem of Drug-Resistant Infections
PR-M10-18-NI-087
Antibiotics
PolyPid Begins Phase 2 Study to Assess Safety and Efficacy of D-PLEX100 in Prevention of Abdominal Surgical Site Infections
PR-M10-18-NI-070
Antibiotics
The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries
PR-M10-18-NI-048
Drug Development
New Antibiotic to be Tested against Potential Bioweapons
PAO-M07-18-NI-009
Antibiotic Resistance
Roche PCT assay cleared for expanded use - Important tool in antibiotic resistance crisis
PR-M07-18-NI-049
Innovation
Funding Round Will Boost Efforts to Develop Antibiotic for Alzheimer’s Disease
PAO-M06-18-NI-005
Antibiotics
Macrolide Attracts Funding and Executive Talent
PAO-M04-18-NI-004
Antibiotic-Resistant
ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-Resistant Bacteria
PR-M02-18-NI-78
Drug Discovery
Defense Department Commits $16 Million to Fight Bacterial Bioweapons
PAO-M01-18-NI-010
Drug Development
NIH Funds Bacterial DNA Superbug Killer
PAO-M11-17-NI-014
Antibiotics
New Class of Antibiotics Looks Promising
PAO-M07-17-NI-017
Data Management
Keeping Track of Antibiotic Resistance Just Got Easier
PAO-M05-17-NI-031
.svg)
